Investors comparing BAH and EXPO are weighing two very different businesses within the broader consulting universe. Booz Allen Hamilton Holding Corporation is a defense- and intelligence-heavy government contractor, while Exponent, Inc. is a specialized science and engineering consultancy serving corporate and government clients. Despite operating in adjacent professional-services sectors, the two stocks have shown sharply different momentum and market positioning in recent months. This comparison is relevant for traders and long-term investors seeking to understand how a large-cap turnaround story stacks up against a smaller, faster-growing specialty firm — and which profile better fits current market conditions.
BAH — Booz Allen Hamilton — provides management and technology consulting, analytics, engineering, and cybersecurity services primarily to U.S. government agencies, including the Department of Defense and intelligence community. Its scale is considerable, with annual revenue of roughly $11 billion.
Recent market activity has been volatile. After a prolonged decline — shares fell roughly 40% from their 52-week high and remain well below that peak — the stock rebounded sharply in recent weeks, gaining more than 10% over a single month. The catalyst was a fiscal first-quarter earnings beat driven by stronger profitability, even though revenue continued to decline. National Security revenue grew modestly while funded backlog and the book-to-bill ratio improved, but the Civil and Commercial segment fell by a double-digit percentage. Management's full-year revenue guidance of roughly 0% to 4% growth underscores the turnaround is still early. Analysts have mixed views, with some recently upgrading the stock while others remain cautious, and the consensus rating stands at Hold.
EXPO — Exponent, Inc. — is a science and engineering consulting firm that investigates complex technical, safety, and regulatory problems for clients across industries including transportation, energy, healthcare, and technology. Its market capitalization is significantly smaller than BAH's, in the low single-digit billions.
Exponent's recent performance has been comparatively strong. In its latest quarterly report, revenue rose roughly 21% year over year and earnings per share beat analyst estimates, supported by expanding demand in high-growth, innovation-driven domains such as artificial-intelligence safety and advanced technologies. Management raised its full-year revenue growth outlook to approximately 9% to 10%. The stock has advanced over recent weeks and is outperforming the broader business-services sector, which has declined year to date. The analyst consensus is a Buy, with an average price target implying notable upside. However, the company trades at a premium price-to-earnings (P/E) multiple relative to many peers, reflecting expectations for continued growth.
For traders looking to systematize decisions like the BAH-versus-EXPO comparison, Tickeron's Trending AI Robots page offers a curated view of its AI-powered trading tools. Tickeron maintains a large fleet of AI Trading Bots spanning thousands of different tickers, yet only a small subset — selected from hundreds of available robots — earns a place in this curated section. These featured bots span a wide range of trading styles, strategies, timeframes, and performance statistics, with displayed metrics such as win rates, profit factors, realized returns, and profit-to-drawdown ratios that vary by strategy and market regime. Because each robot differs in its approach and ticker coverage, the page helps traders identify which automated strategies are currently best suited to prevailing conditions. Explore the Trending AI Robots to review the current lineup.
The two companies differ fundamentally in business model and risk profile. BAH derives the bulk of its revenue from federal contracts, which provides recurring, mission-critical demand but also exposes it to budget cycles and procurement shifts. Its current challenge is a contracting civil business dragging down consolidated growth, offset only partially by national security strength and margin expansion. EXPO, by contrast, serves a diversified mix of commercial and government clients on shorter, project-based engagements, giving it faster revenue growth but less contract-based revenue visibility.
On momentum, EXPO has the clear edge, with accelerating revenue and a rising earnings outlook. BAH's momentum is a recovery story built on bottom-line beats rather than top-line expansion. On valuation, BAH trades at a discount on a forward earnings basis and offers a higher dividend yield, while EXPO commands a premium multiple backed by growth. Risk factors also differ: BAH faces concentration in federal spending and leverage considerations, whereas EXPO faces utilization and staffing-efficiency risks plus a richer valuation. Sentiment favors EXPO, which carries a Buy consensus, versus BAH's Hold consensus and wider analyst dispersion.
Based on observable factors — trend consistency, growth catalysts, earnings momentum, and relative positioning — Tickeron's AI would likely favor EXPO in the current environment. Exponent's combination of accelerating revenue growth, rising guidance, positive earnings estimate revisions, and a Buy-rated analyst consensus reflects a more consistent and constructive trend profile. BAH's improving margins and backlog are notable, but its still-declining revenue and concentrated federal exposure introduce greater uncertainty. That said, BAH's discounted valuation and elevated dividend yield could appeal to value- and income-oriented strategies if its recovery broadens. The AI verdict is probabilistic, weighting the steadier, growth-oriented setup currently presented by EXPO over BAH's less certain turnaround.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for BAH crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on BAH as a result. In 50 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for BAH just turned positive on October 12, 2026. Looking at past instances where BAH's MACD turned positive, the stock continued to rise in 23 of 39 cases over the following month. The odds of a continued upward trend are 59%.
BAH moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAH advanced for three days, in 180 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The 10-day RSI Indicator for BAH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In 28 of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BAH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BAH entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. BAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.838) is normal, around the industry mean (12.731). P/E Ratio (12.276) is within average values for comparable stocks, (47.114). Projected Growth (PEG Ratio) (1.210) is also within normal values, averaging (2.814). Dividend Yield (0.030) settles around the average of (0.037) among similar stocks. P/S Ratio (0.857) is also within normal values, averaging (25.562).
The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for EXPO turned positive on October 02, 2026. Looking at past instances where EXPO's MACD turned positive, the stock continued to rise in 29 of 45 cases over the following month. The odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on EXPO as a result. In 56 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
EXPO moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for EXPO crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +5.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXPO advanced for three days, in 162 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXPO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
EXPO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EXPO entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. EXPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.756) is normal, around the industry mean (15.366). P/E Ratio (34.567) is within average values for comparable stocks, (168.980). Projected Growth (PEG Ratio) (2.730) is also within normal values, averaging (3.522). Dividend Yield (0.016) settles around the average of (0.194) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (2.905).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
BAH | EXPO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 74 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 95 | 100 | |
SMR RATING 1..100 | 17 | 31 | |
PRICE GROWTH RATING 1..100 | 50 | 39 | |
P/E GROWTH RATING 1..100 | 39 | 41 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BAH's Valuation (66) in the Miscellaneous Commercial Services industry is in the same range as EXPO (88) in the Engineering And Construction industry. This means that BAH’s stock grew similarly to EXPO’s over the last 12 months.
BAH's Profit vs Risk Rating (95) in the Miscellaneous Commercial Services industry is in the same range as EXPO (100) in the Engineering And Construction industry. This means that BAH’s stock grew similarly to EXPO’s over the last 12 months.
BAH's SMR Rating (17) in the Miscellaneous Commercial Services industry is in the same range as EXPO (31) in the Engineering And Construction industry. This means that BAH’s stock grew similarly to EXPO’s over the last 12 months.
EXPO's Price Growth Rating (39) in the Engineering And Construction industry is in the same range as BAH (50) in the Miscellaneous Commercial Services industry. This means that EXPO’s stock grew similarly to BAH’s over the last 12 months.
BAH's P/E Growth Rating (39) in the Miscellaneous Commercial Services industry is in the same range as EXPO (41) in the Engineering And Construction industry. This means that BAH’s stock grew similarly to EXPO’s over the last 12 months.
| BAH | EXPO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 58% | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 54% | 2 days ago 61% |
| Momentum ODDS (%) | 2 days ago 60% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 59% | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 56% |
| Advances ODDS (%) | 3 days ago 57% | 2 days ago 58% |
| Declines ODDS (%) | 6 days ago 58% | about 1 month ago 60% |
| BollingerBands ODDS (%) | 2 days ago 61% | 2 days ago 57% |
| Aroon ODDS (%) | 2 days ago 63% | 2 days ago 59% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAH’s FA Score shows that 1 FA rating(s) are green while EXPO’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAH’s TA Score shows that 5 TA indicator(s) are bullish while EXPO’s TA Score has 5 bullish TA indicator(s).
BAH (@Data Processing Services) experienced а +5.47% price change this week, while EXPO (@Engineering & Construction) price change was +7.77% for the same time period.
The average weekly price growth across all stocks in the @Data Processing Services industry was +1.21%. For the same industry, the average monthly price growth was -2.69%, and the average quarterly price growth was -2.97%.
The average weekly price growth across all stocks in the @Engineering & Construction industry was -5.11%. For the same industry, the average monthly price growth was -15.13%, and the average quarterly price growth was -29.76%.
BAH is expected to report earnings on Jan 22, 2027.
EXPO is expected to report earnings on Oct 29, 2026.
The industry involves capturing raw data from various sources, extracting meaningful information from it and presenting it in a more accessible digital format. Many people would agree that data is the new gold, which makes data processing services all the more relevant for businesses’ strategic decisions. PayPal Holdings Inc., Fidelity National Information Services, Inc. and Automatic Data Processing, Inc. some of the big players in his burgeoning industry.
@Engineering & Construction (-5.11% weekly)Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ZMUN | 49.96 | 0.04 | +0.07% |
| F/m Ultrashort Tax-Free Municipal ETF (ZMUN) | |||
| DDFN | 20.62 | -0.04 | -0.19% |
| Innovator Equity Dual Directional 15 Buffer ETF - November (DDFN) | |||
| SOR | 45.14 | -0.50 | -1.10% |
| Source Capital | |||
| DSTL | 69.52 | -0.82 | -1.17% |
| Distillate US Fundamental Stability & Value ETF (DSTL) | |||
| XDEF | 20.56 | -0.49 | -2.34% |
| Xtrackers Europe Defense Technologies ETF (XDEF) | |||
A.I.dvisor indicates that over the last year, BAH has been loosely correlated with EXPO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BAH jumps, then EXPO could also see price increases.
| Ticker / NAME | Correlation To BAH | 1D Price Change % | ||
|---|---|---|---|---|
| BAH | 100% | -0.32% | ||
| EXPO - BAH | 50% Loosely correlated | +0.41% | ||
| FCN - BAH | 43% Loosely correlated | -0.22% | ||
| MMS - BAH | 39% Loosely correlated | -0.57% | ||
| EFX - BAH | 35% Loosely correlated | -2.55% | ||
| CPRT - BAH | 33% Loosely correlated | -0.31% | ||
More | ||||